$59.06
At close: May 21, 5:00 PM EST
$59.95
0.891.50%
After Hours: 5:46 PM EST
Corcept Therapeutics Inc Earnings Estimates
CORTNASDAQ
Corcept Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CORT
Corcept Therapeutics (CORT) is scheduled to report Q2 earnings on July 30, 2026. Analysts estimate EPS of $0.02 and quarterly revenue of $221.00M.
In the most recent quarter (Q1), Corcept Therapeutics reported EPS of $-0.30, missing estimates of $-0.17 by 0.76%. Revenue came in at $164.90M, missing the estimate of $183.78M by 0.10%.
Corcept Therapeutics has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Corcept Therapeutics has averaged an EPS surprise of 0.41% and a revenue surprise of 0.10%.
Earnings Date
Jul 30
EPS Estimate
$0.020
Quarterly Revenue Estimate
$221.00M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$769.10M
Corcept Therapeutics Earnings History
Analyze the earnings history of Corcept Therapeutics using advanced sorting and filters.
Loading calendar...
Corcept Therapeutics (CORT) Earnings Per Share
The chart below shows Corcept Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Corcept Therapeutics (CORT) Revenue
The chart below shows Corcept Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Corcept Therapeutics (NASDAQ:CORT) reporting earnings?
Corcept Therapeutics (CORT) is scheduled to report earnings on July 30, 2026. The last reported earnings were for reported on April 30, 2026 for Q1.
What were the latest earnings per share (EPS) for Corcept Therapeutics (NASDAQ:CORT)?
The Actual EPS was $-0.30, which missed the estimate of $-0.17.
What were Corcept Therapeutics’s (NASDAQ:CORT) revenues?
The Actual Revenue was $164.90M, which missed the estimate of $183.78M.
